Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Universidade de Coimbra
- UNIVERSITY OF HELSINKI
- Medical University of Lublin
- University Medical Center Utrecht (UMC Utrecht)
- Ageing better colab
- Faculty of Sciences of the University of Porto
- ODTÜ-GÜNAM
- Technical University of Munich
- University of Minho
- University of Stuttgart
- 1 more »
- « less
-
Field
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 17 days ago
regulation and lymphoma pathogenesis, has emerged as a promising candidate. We showed that PSGL-1 blockade with a monoclonal antibody (mAb) enhances T cell activation, alters the lymphoma immune
-
cell types and simulate their interactions with joint tissues. You will implement and validate molecular reporter technologies to monitor neuronal activation and pain-related signaling pathways, and
-
related to staff position within a Research Infrastructure? No Offer Description Location: Institute of Cell Biology and Immunology, University of Stuttgart, Germany Group Leader: Dr. Andrew G. Clark
-
professional development. YOUR PROFILE Highly motivated with a second cycle academic degree (MSc, MD or equivalent) in biology, biochemistry, bioinformatics, biotechnology, cell biology, computer
-
, bioinformatics, biotechnology, cell biology, computer science, genetics, medicine, or other related fields, obtained before the start of the position (August 2026). Strong analytical and quantitative skills with
-
@odtugunam.org Subject:Application – Passivating Contact Silicon Solar Cells Researcher Website for additional job details https://odtugunam.org/hr/researcher-in-passivating-contact-silicon-solar-cells/ Work
-
the project and supervise day-to-day laboratory activities. Perform in vitro experiments on bone implants using cell cultures, including primary human cells and established cell lines. Assess cell
-
Strategies group at the Centre for Neuroscience and Cell Biology at the University of Coimbra, in the field of cancer nanomedicine and within the scope of the BINANOTREATCANCER project. The chosen candidate
-
of Genome Function and Cell Identity, relevant for stem cell biology and cancer. In total, there are 14 beneficiaries and 12 partner organisations. Where to apply Website https://www.academictransfer.com/en
-
targeting of host cell interactions in alphaviruses. Viruses with RNA genomes cause most of the emerging and re-emerging infectious disease epidemics. Alphaviruses are mosquito-borne viruses causing febrile